419 related articles for article (PubMed ID: 3895657)
1. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
[No Abstract] [Full Text] [Related]
2. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone.
Simmons RL; Canafax DM; Strand M; Ascher NL; Payne WD; Sutherland DE; Najarian JS
Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665
[No Abstract] [Full Text] [Related]
3. The case against conversion to azathioprine in cyclosporine-treated renal recipients.
Flechner SM; Lorber M; Van Buren C; Kerman R; Kahan BD
Transplant Proc; 1985 Aug; 17(4 Suppl 1):276-81. PubMed ID: 3895667
[No Abstract] [Full Text] [Related]
4. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation.
Landsberg D; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
Transplant Proc; 1989 Apr; 21(2):3323-4. PubMed ID: 2652826
[No Abstract] [Full Text] [Related]
5. Triple therapy with low-dose cyclosporine, azathioprine, and steroids: long-term results of a randomized study in cadaver donor renal transplantation.
Fries D; Hiesse C; Santelli G; Gardin JP; Cantarovich M; Lantz O; Charpentier B; Paillard M; Benoit G
Transplant Proc; 1988 Jun; 20(3 Suppl 3):130-5. PubMed ID: 3291226
[No Abstract] [Full Text] [Related]
6. A retrospective analysis of long-term renal allograft function associated with cyclosporine-prednisone immunosuppressive therapy.
Lewis RM; Janney RP; Van Buren CT; Kerman RH; Herson J; Kerr NA; Golden DA; Kahan BD
Transplant Proc; 1988 Jun; 20(3 Suppl 3):534-9. PubMed ID: 3291291
[No Abstract] [Full Text] [Related]
7. Renal transplants maintained on low-dose cyclosporine and prednisolone.
Rogerson ME; Neild GH; Rudge CJ; Wood SM; Cairns HS; Mansell MA; Thompson FD
Transplant Proc; 1988 Jun; 20(3 Suppl 3):114-6. PubMed ID: 3291222
[No Abstract] [Full Text] [Related]
8. Stability of renal allograft recipients after conversion from cyclosporine to azathioprine.
Carpenter CB; Milford EL; Kirkman RL; Strom TB; Lazarus JM; Tilney NL
Transplant Proc; 1985 Aug; 17(4 Suppl 1):261-5. PubMed ID: 3927537
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine.
Ford HR; Fryd DS; Canafax DM; Ascher NL; Dunn D; Sutherland DE; Najarian JS; Simmons RL
Transplant Proc; 1988 Jun; 20(3 Suppl 3):8-12. PubMed ID: 3291316
[No Abstract] [Full Text] [Related]
10. A single center experience with "low-dose" cyclosporine in cadaveric renal transplantation.
Fries D; Hiesse C; Charpentier B; Lantz O; Bensadoun H; Benoit G
Clin Transpl; 1988; ():115-29. PubMed ID: 3154465
[No Abstract] [Full Text] [Related]
11. First month cyclosporine A sparing in renal transplantation.
Segoloni GP; Messina M; Colla L; Piccoli GB; Triolo G; Vercellone A
Transplant Proc; 1988 Jun; 20(3 Suppl 3):233-8. PubMed ID: 3291249
[No Abstract] [Full Text] [Related]
12. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
[No Abstract] [Full Text] [Related]
13. A prospective study of conversion from cyclosporine to azathioprine: comparison of clinical and morphologic findings.
Abbud-Filho M; Ramalho HJ; Barberato JB; Corrente JE; Salgueiro MC; Mazzetto MR; Bezas AG
Transplant Proc; 1988 Jun; 20(3 Suppl 3):164-8. PubMed ID: 3291235
[No Abstract] [Full Text] [Related]
14. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
Chapman JR; Morris PJ
Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
[No Abstract] [Full Text] [Related]
15. Combination therapy of cyclosporine and azathioprine in living-related kidney transplant recipients compared with patients converted totally from cyclosporine to azathioprine.
Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Nakai I
Transplant Proc; 1988 Jun; 20(3 Suppl 3):143-6. PubMed ID: 3291229
[No Abstract] [Full Text] [Related]
16. Consequences of conversion from cyclosporine to conventional therapy in renal transplantation.
Abbud-Filho M; Barberato JB; Ramalho HJ; Saldanha LB; Casassanta DM; Denadai ER; Zerati S; Bezas AG
Transplant Proc; 1989 Feb; 21(1 Pt 2):1638-40. PubMed ID: 2652535
[No Abstract] [Full Text] [Related]
17. Low doses of cyclosporine, azathioprine, and prednisone in renal transplantation: immunosuppressive efficacy and reduced nephrotoxicity.
Pallardo LM; Sanchez J; Garcia J; Moreno RF; Rochera A; Cabezuelo J
Transplant Proc; 1988 Oct; 20(5 Suppl 6):26-7. PubMed ID: 3051582
[No Abstract] [Full Text] [Related]
18. The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation.
Landsberg DN; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
Transplant Proc; 1989 Feb; 21(1 Pt 2):1550-1. PubMed ID: 2652502
[No Abstract] [Full Text] [Related]
19. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
[No Abstract] [Full Text] [Related]
20. The course of chronic, progressive renal allograft dysfunction during cyclosporine therapy is modified by addition of azathioprine.
Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Turcotte JG; Campbell DA
Transplant Proc; 1989 Feb; 21(1 Pt 2):1529-31. PubMed ID: 2652493
[No Abstract] [Full Text] [Related]
[Next] [New Search]
